Published in J Sex Med on September 04, 2014
Genetic differences may reflect differences in susceptibility to vulvodynia in general or in spontaneous remission propensity. J Sex Med (2014) 1.07
Genetic differences may reflect differences in susceptibility to vulvodynia in general or in spontaneous remission propensity: a response. J Sex Med (2015) 0.75
Recent advances in understanding provoked vestibulodynia. F1000Res (2016) 0.75
The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc (2012) 3.45
Testosterone therapy in men with untreated prostate cancer. J Urol (2011) 3.08
Zotarolimus-eluting peripheral stents for the treatment of erectile dysfunction in subjects with suboptimal response to phosphodiesterase-5 inhibitors. J Am Coll Cardiol (2012) 2.85
Risk factors for primary and subsequent anal sphincter lacerations: a comparison of cohorts by parity and prior mode of delivery. Am J Obstet Gynecol (2007) 2.45
Varicocele repair in patients with nonobstructive azoospermia: a meta-analysis. J Urol (2010) 2.31
Penile constriction devices: case report, review of the literature, and recommendations for extrication. J Sex Med (2008) 2.19
Characteristics of premenopausal and postmenopausal women with acquired, generalized hypoactive sexual desire disorder: the Hypoactive Sexual Desire Disorder Registry for women. Menopause (2012) 2.09
Hematoma resolution as a target for intracerebral hemorrhage treatment: role for peroxisome proliferator-activated receptor gamma in microglia/macrophages. Ann Neurol (2007) 2.05
Testosterone replacement therapy in patients with prostate cancer after radical prostatectomy. J Urol (2013) 1.90
Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol (2005) 1.83
Testosterone and erectile function: from basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction. Eur Urol (2007) 1.79
Testosterone therapy and cardiovascular risk: advances and controversies. Mayo Clin Proc (2015) 1.70
A critical analysis of the role of testosterone in erectile function: from pathophysiology to treatment-a systematic review. Eur Urol (2013) 1.70
Peptic ulcer/stricture after gastric bypass: a comparison of technique and acid suppression variables. Obes Surg (2002) 1.67
Vulvodynia: a state-of-the-art consensus on definitions, diagnosis and management. J Reprod Med (2006) 1.66
Impact of oral contraceptives on sex hormone-binding globulin and androgen levels: a retrospective study in women with sexual dysfunction. J Sex Med (2006) 1.63
That's one small step for medicine, one giant leap for sexual medicine. J Sex Med (2007) 1.63
International Society for Sexual Medicine's guidelines for the diagnosis and treatment of premature ejaculation. J Sex Med (2010) 1.60
Interrelationship of sildenafil treatment effects on the physiological and psychosocial aspects of erectile dysfunction of mixed or organic etiology. J Sex Med (2010) 1.53
The treatment of hypogonadism in men of reproductive age. Fertil Steril (2012) 1.52
Baseline characteristics from an ongoing phase 3 study of collagenase clostridium histolyticum in patients with Peyronie's disease. J Sex Med (2013) 1.52
Erectile dysfunction diagnosis and treatment as a means to improve medication adherence and optimize comorbidity management. J Sex Med (2012) 1.47
The current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women. J Sex Med (2008) 1.44
Effects of androgen on the expression of vascular endothelial growth factor in the penile corpus cavernosum. Urology (2011) 1.43
Summary of the recommendations on sexual dysfunctions in men. J Sex Med (2010) 1.42
Etiology and treatment of overactive bladder in women. South Med J (2011) 1.40
An old problem with a new cause-5 alpha reductase inhibitors and persistent sexual dysfunction. J Sex Med (2011) 1.40
Summary of the recommendations on sexual dysfunctions in women. J Sex Med (2004) 1.40
Validity of the decreased sexual desire screener for diagnosing hypoactive sexual desire disorder. J Sex Marital Ther (2013) 1.40
Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment. Fertil Steril (2002) 1.35
Anatomy, physiology, and pathophysiology of erectile dysfunction. J Sex Med (2010) 1.35
Re-engineered CD40 receptor enables potent pharmacological activation of dendritic-cell cancer vaccines in vivo. Nat Med (2005) 1.31
Human arginase II: crystal structure and physiological role in male and female sexual arousal. Biochemistry (2003) 1.30
The validity of a single-question self-report of erectile dysfunction. Results from the Massachusetts Male Aging Study. J Gen Intern Med (2005) 1.28
Toward personalized sexual medicine (part 2): testosterone combined with a PDE5 inhibitor increases sexual satisfaction in women with HSDD and FSAD, and a low sensitive system for sexual cues. J Sex Med (2012) 1.23
Sexual experience of female partners of men with erectile dysfunction: the female experience of men's attitudes to life events and sexuality (FEMALES) study. J Sex Med (2005) 1.21
Toward personalized sexual medicine (part 1): integrating the "dual control model" into differential drug treatments for hypoactive sexual desire disorder and female sexual arousal disorder. J Sex Med (2012) 1.19
Bicycle riding and erectile dysfunction: a review. J Sex Med (2010) 1.17
Prophylactic bilateral oophorectomy or removal of remaining ovary at the time of hysterectomy in the United States, 1979-2004. Am J Obstet Gynecol (2010) 1.14
Validation of the erection hardness score. J Sex Med (2007) 1.11
North American consensus document on infection of penile prostheses. Urology (2013) 1.09
Early postoperative peripheral blood reverse transcription PCR assay for prostate-specific antigen is associated with prostate cancer progression in patients undergoing radical prostatectomy. Cancer Res (2003) 1.07
Malignant priapism secondary to metastatic prostate cancer: a case report and review of literature. Rev Urol (2011) 1.07
RE: Testosterone treatment is a potent tumor promoter for the rat prostate. Endocrinology (2015) 1.07
Adipocyte accumulation in penile corpus cavernosum of the orchiectomized rabbit: a potential mechanism for veno-occlusive dysfunction in androgen deficiency. J Androl (2005) 1.04
Effects of medical or surgical castration on erectile function in an animal model. J Androl (2003) 1.03
Modulation of rat vaginal blood flow and estrogen receptor by estradiol. J Urol (2004) 1.01
Cardiometabolic risk and female sexual health: the Princeton III summary. J Sex Med (2012) 1.01
Only the nose knows: penile hemodynamic study of the perineum-saddle interface in men with erectile dysfunction utilizing bicycle saddles and seats with and without nose extensions. J Sex Med (2005) 1.00
Differential effects of estradiol, progesterone, and testosterone on vaginal structural integrity. Endocrinology (2005) 1.00
Bicycle riding and erectile dysfunction: an increase in interest (and concern). J Sex Med (2005) 0.99
Diagnosis and treatment of erectile dysfunction for reduction of cardiovascular risk. J Urol (2013) 0.97
Penile injection with silicone: case report and review of the literature. J Sex Med (2008) 0.97
Improving the sexual quality of life of couples affected by erectile dysfunction: a double-blind, randomized, placebo-controlled trial of vardenafil. J Sex Med (2005) 0.96
Persistent genital arousal disorder (PGAD): case report of long-term symptomatic management with electroconvulsive therapy. J Sex Med (2009) 0.96
Effect of 12 months of testosterone replacement therapy on metabolic syndrome components in hypogonadal men: data from the Testim Registry in the US (TRiUS). BMC Endocr Disord (2011) 0.94
Clinical biologic pathophysiologies of women's sexual dysfunction. J Sex Med (2005) 0.94
Percutaneous treatment of varicocele with microcoil embolization: comparison of treatment outcome with laparoscopic varicocelectomy. Vascular (2009) 0.94
A double-blind, randomized controlled trial of clobetasol versus pimecrolimus in patients with vulvar lichen sclerosus. J Am Acad Dermatol (2011) 0.93
The phosphatase SRC homology region 2 domain-containing phosphatase-1 is an intrinsic central regulator of dendritic cell function. J Immunol (2011) 0.93
A review of the physiology and pharmacology of peripheral (vaginal and clitoral) female genital arousal in the animal model. J Urol (2003) 0.91
Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol (2005) 0.91
Biochemical factors modulating female genital sexual arousal physiology. J Sex Med (2010) 0.90
Favorable female sexual function is associated with patient satisfaction after inflatable penile prosthesis implantation. J Sex Med (2011) 0.90
Reperfusion of ischemic corporal tissue: physiologic and biochemical changes in an animal model of ischemic priapism. Urology (2003) 0.90
Commentary: Who is a candidate for testosterone therapy? A synthesis of international expert opinions. J Sex Med (2014) 0.90
Dose-response relationship between testosterone and erectile function: evidence for the existence of a critical threshold. J Androl (2006) 0.89
Streptozotocin-induced diabetes in the rat is associated with changes in vaginal hemodynamics, morphology and biochemical markers. BMC Physiol (2006) 0.89
Persistent genital arousal disorder: a case report in a woman with lifelong PGAD where serendipitous administration of varenicline tartrate resulted in symptomatic improvement. J Sex Med (2009) 0.88
Preoperative blood reverse transcriptase-PCR assays for prostate-specific antigen and human glandular kallikrein for prediction of prostate cancer progression after radical prostatectomy. Cancer Res (2002) 0.88
An in vivo rat model to investigate female vaginal arousal response. J Urol (2004) 0.88
The female factor: predicting compliance with a post-prostatectomy erectile preservation program. J Sex Med (2010) 0.87
Internet-ordered viagra (sildenafil citrate) is rarely genuine. J Sex Med (2012) 0.87
Prophylactic antibiotics after urodynamics in women: a decision analysis. Int Urogynecol J Pelvic Floor Dysfunct (2006) 0.86
Premature to early ejaculation: a sampling of manuscripts regarding the most common male sexual dysfunction published in the IJIR: The Journal of Sexual Medicine. Int J Impot Res (2003) 0.86
Physiological normal levels of androgen inhibit proliferation of prostate cancer cells in vitro. Asian J Androl (2014) 0.86
Cocaine and ephedrine-induced priapism: case reports and investigation of potential adrenergic mechanisms. Urology (2003) 0.85
Does radical nephrectomy increase the risk of erectile dysfunction compared with partial nephrectomy? A cohort analysis. BJU Int (2012) 0.85
The 20-year public health impact and direct cost of testosterone deficiency in U.S. men. J Sex Med (2012) 0.85
Biochemical and functional characterization of alpha-adrenergic receptors in the rabbit vagina. Life Sci (2002) 0.85
A multi-institutional observational study of testosterone levels after testosterone pellet (Testopel(®)) insertion. J Sex Med (2012) 0.84
Pharmacokinetic evaluation and dosing of subcutaneous testosterone pellets. J Androl (2012) 0.84
Adulteration of purported herbal and natural sexual performance enhancement dietary supplements with synthetic phosphodiesterase type 5 inhibitors. J Sex Med (2013) 0.84
Testosterone replacement therapy among elderly males: the Testim Registry in the US (TRiUS). Clin Interv Aging (2012) 0.83
Correlations with satisfaction measures in men treated with phosphodiesterase inhibitors for erectile dysfunction. Am J Mens Health (2011) 0.83
Delivering enhanced testosterone replacement therapy through nanochannels. Adv Healthc Mater (2014) 0.83
Erectile dysfunction. Am J Nurs (2003) 0.83
Effects of ovariectomy and estrogen and androgen treatment on sildenafil-mediated changes in female genital blood flow and vaginal lubrication in the animal model. Am J Obstet Gynecol (2002) 0.82
12-month observation of testosterone replacement effectiveness in a general population of men. Postgrad Med (2013) 0.82